138 related articles for article (PubMed ID: 22916420)
1. [Uric acid 8.4 in an asymptomatic patient. Does he need medication?].
Füessl HS
MMW Fortschr Med; 2012 Jun; O 154 Suppl 2():22. PubMed ID: 22916420
[No Abstract] [Full Text] [Related]
2. Lesinurad/allopurinol (Duzallo) for gout-associated hyperuricemia.
Med Lett Drugs Ther; 2017 Nov; 59(1533):182-183. PubMed ID: 29125593
[No Abstract] [Full Text] [Related]
3. Clinical trials of uric acid lowering for coronary heart disease risk reduction.
Simon JA
Am J Med; 2006 Apr; 119(4):e5; author reply e7. PubMed ID: 16564763
[No Abstract] [Full Text] [Related]
4. Approach to the treatment of hyperuricemia.
Poon SH; Hall HA; Zimmermann B
Med Health R I; 2009 Nov; 92(11):359-62. PubMed ID: 19999894
[No Abstract] [Full Text] [Related]
5. Emerging uricosurics for gout.
Terkeltaub R
Expert Rev Clin Pharmacol; 2017 Mar; 10(3):247-249. PubMed ID: 27937050
[No Abstract] [Full Text] [Related]
6. Efficacy of benzbromarone in hyperuricemic patients associated with chronic kidney disease.
Fujimori S; Ooyama K; Ooyama H; Moromizato H
Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1035-8. PubMed ID: 22132953
[TBL] [Abstract][Full Text] [Related]
7. [Should asymptomatic hyperuricemia be treated?].
Gerster JC
Rev Med Suisse Romande; 1983 May; 103(5):457-60. PubMed ID: 6878975
[No Abstract] [Full Text] [Related]
8. [Drug-induced hypouricemia: pathophysiology and application to the hyperuricemia with life style related disease].
Hisatome I; Ogino K; Igawa O; Shigemasa C
Nihon Rinsho; 2003 Jan; 61 Suppl 1():403-9. PubMed ID: 12629757
[No Abstract] [Full Text] [Related]
9. [Effect of jianpihuashi decoction on rats with hyperuricemia].
Chen JW; Zhou Y; Xue ZY; Li C; Guo J; Zhou LY; Jiang JM
Zhong Yao Cai; 2013 Sep; 36(9):1486-9. PubMed ID: 24620698
[TBL] [Abstract][Full Text] [Related]
10. Effects of uric acid-lowering therapy on the progression of chronic kidney disease: a systematic review and meta-analysis.
Liu X; Zhai T; Ma R; Luo C; Wang H; Liu L
Ren Fail; 2018 Nov; 40(1):289-297. PubMed ID: 29619870
[TBL] [Abstract][Full Text] [Related]
11. Hyperuricemia and gout.
Klinenberg JR
Med Clin North Am; 1977 Mar; 61(2):299-312. PubMed ID: 323595
[No Abstract] [Full Text] [Related]
12. Relationship between serum allantoin and urate in healthy subjects and effects of benzbromarone in gout patients.
Kurajoh M; Koyama H; Shoji T; Sumida C; Yamamoto A; Tsutsumi Z; Moriwaki Y; Yamamoto T; Koga M
Int J Clin Pharmacol Ther; 2012 Apr; 50(4):265-71. PubMed ID: 22456297
[TBL] [Abstract][Full Text] [Related]
13. Management of asymptomatic hyperuricemia.
Duffy WB; Senekjian HO; Knight TF; Weinman EJ
JAMA; 1981 Nov; 246(19):2215-6. PubMed ID: 7289015
[TBL] [Abstract][Full Text] [Related]
14. [Clinical course and management of asymptomatic hyperuricemia].
Nishida Y
Nihon Rinsho; 1991 May; 49(5):1086-92. PubMed ID: 2067099
[No Abstract] [Full Text] [Related]
15. Treatment of hyperuricemia.
Rodney WM
JAMA; 1980 Jul; 244(4):332. PubMed ID: 7392121
[No Abstract] [Full Text] [Related]
16. [Serum uric acid--a cardiovasular risk factor?].
Alderman M; Redfern JS
Ther Umsch; 2004 Sep; 61(9):547-52. PubMed ID: 15493113
[TBL] [Abstract][Full Text] [Related]
17. [When and how to treat hyperuricemia].
Rubens-Duval A
Therapeutique; 1973 Apr; 49(4):263-5. PubMed ID: 4775219
[No Abstract] [Full Text] [Related]
18. Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled crossover preliminary study.
Ogino K; Kato M; Furuse Y; Kinugasa Y; Ishida K; Osaki S; Kinugawa T; Igawa O; Hisatome I; Shigemasa C; Anker SD; Doehner W
Circ Heart Fail; 2010 Jan; 3(1):73-81. PubMed ID: 19933411
[TBL] [Abstract][Full Text] [Related]
19. [Advances in drugs used to normalize hyperuricemia].
Tofuku Y; Hirata M
Nihon Rinsho; 1991 May; 49(5):1081-5. PubMed ID: 2067098
[No Abstract] [Full Text] [Related]
20. [Uninterrupted therapy of hyperuricemia and gout].
Schilling F
Reumatizam; 1971; 18(3):79-82. PubMed ID: 5097291
[No Abstract] [Full Text] [Related]
[Next] [New Search]
